Next Article in Journal
Well-Being and Performance of Nursery Pigs Subjected to Different Commercial Vaccines Against Porcine Circovirus Type 2, Mycoplasma hyopneumoniae and Lawsonia intracellularis
Next Article in Special Issue
Incidence of SARS-CoV-2 Infection Among European Healthcare Workers and Effectiveness of the First Booster COVID-19 Vaccine, VEBIS HCW Observational Cohort Study, May 2021–May 2023
Previous Article in Journal
Development of Long-Term Stability of Enveloped rVSV Viral Vector Expressing SARS-CoV-2 Antigen Using a DOE-Guided Approach
Previous Article in Special Issue
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates
 
 
vaccines-logo
Article Menu
Brief Report

Article Versions Notes

Vaccines 2024, 12(11), 1241; https://doi.org/10.3390/vaccines12111241
Action Date Notes Link
article xml file uploaded 31 October 2024 10:08 CET Original file -
article xml uploaded. 31 October 2024 10:08 CET Update -
article pdf uploaded. 31 October 2024 10:08 CET Version of Record https://www.mdpi.com/2076-393X/12/11/1241/pdf-vor
article supplementary file uploaded. 31 October 2024 10:08 CET - https://www.mdpi.com/2076-393X/12/11/1241#supplementary
article html file updated 31 October 2024 10:10 CET Original file -
article xml file uploaded 5 November 2024 09:38 CET Update -
article xml uploaded. 5 November 2024 09:38 CET Update https://www.mdpi.com/2076-393X/12/11/1241/xml
article pdf uploaded. 5 November 2024 09:38 CET Updated version of record https://www.mdpi.com/2076-393X/12/11/1241/pdf
article html file updated 5 November 2024 09:41 CET Update https://www.mdpi.com/2076-393X/12/11/1241/html
Back to TopTop